SWStefan Wolf

Stefan Wolf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Stefan Wolf has a total of 198 co-authors. Here are the top co-authors by number of shared publications:

  • Peter Vajkoczy

    10 shared publications
  • Farid Salih

    Neurologische Klinik und Poliklinik, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany

    6 shared publications
  • Anton Früh

    Department of Neurosurgery, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany; BIH Biomedical Innovation Academy, BIH Charité Junior Digital Clinician Scientist Program, Charitéplatz 1, 10117 Berlin, Germany

    4 shared publications
  • Christoph Rosenthal

    Klinik für Anästhesiologie mit Schwerpunkt operative Intensivmedizin (Interdisziplinäre Neurointensivstation), Charite-Universitätsmedizin Berlin

    3 shared publications
  • David Wasilewski

    Department of Neurosurgery, Charité Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany; German Cancer Consortium (DKTK), partner site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany

    3 shared publications
  • L. Schürer

    Klinikum Bogenhausen

    3 shared publications

Latest Publications

  • Open Access

    Religion and Religiosity in End-of-Life Decisions in Neurocritical Care

    by Hannah M. Tempel, Stefan Wolf, Farid Salih

    Objectives: End-of-life decisions are shaped by diverse biographical, social, and cultural factors. Few studies have systematically examined the impact of religion on end-of-life decisions, and even less data are available on religiosity (i.e., strength of religious faith). The Religion and religiosity in End-of-life deCisiOns in neuroCritIcaL carE (RECONCILE) study aimed to investigate whether religiosity, rather than religion, plays a decisive role in shaping end-of-life decisions. Design: Prospective observational study. Setting: The study was conducted between 2021 and 2024 at two neuro-ICUs at Charité—Universitätsmedizin Berlin. Patients: We prospectively studied patients with acute brain injury and poor neurologic prognosis defined by the absence of regaining decision-making capacity or sufficient autonomy. A total of 100 patients were included. Interventions: None. Measurements: Relatives were consulted to ascertain the patients’ presumed wishes regarding the continuation or withdrawal of life-sustaining intensive care. The 10-item Santa Clara Strength of Religious Faith questionnaire was applied to measure the patient´s religiosity on a scale between 10 and 40 points. We applied the t -test for independent variables to evaluate the influence of religiosity on end-of-life decisions. To adjust for possible confounders like age, sex, nationality, and religion, we calculated a logistic regression as well as an analysis of variance calculation. Main Results: In patients in whom intensive care was continued, the median score was significantly higher compared with patients in whom intensive care was withdrawn (28.1 ± 9.0 vs. 20.5 ± 8.3; p < 0.001; Cohens d = 0.875). This finding was reproduced in each denominational group. Religion, age, and sex showed no significant association with the end-of-life decision behavior. Germans chose withdrawal of therapy significantly more often than non-Germans ( p = 0.01) but also showed significantly lower religiosity scores (21.9 vs. 27.9; p = 0.003). Conclusions: The RECONCILE study demonstrates that religiosity looks more important in influencing end-of-life decisions than religion. Higher levels of religiosity were associated with a preference for more aggressive treatment, even when neurologic prognosis is poor .

  • Open Access

    Association of Fluid Balance and Hemoglobin Decline With Neurological Outcome After Aneurysmal Subarachnoid Hemorrhage*

    by Peter Truckenmueller, Stefan Wolf, David Wasilewski, Peter Vajkoczy, Anton Früh, for the Earlydrain Study Group

    OBJECTIVES: To explore the relationship between fluid balance and hemoglobin decline with secondary infarctions and neurologic outcome in aneurysmal subarachnoid hemorrhage (aSAH) patients. DESIGN: Secondary analysis of the Earlydrain trial, a prospective randomized controlled study investigating prophylactic lumbar drain use in aSAH patients. SETTING: Patients with aSAH treated in ICUs at 19 tertiary hospitals in Germany, Switzerland, and Canada. PATIENTS: From January 2011 to January 2016, 287 patients were enrolled in the Earlydrain trial. Only files with complete information on both daily hemoglobin and balance values were used, leaving 237 patients for analysis. INTERVENTIONS: Investigation of fluid balance management and hemoglobin levels during the initial 8 days post-aSAH to establish thresholds for unfavorable outcomes and assess their impact on secondary infarctions and 6-month neurologic outcome on the modified Rankin Scale (mRS). MEASUREMENTS AND MAIN RESULTS: Patients with unfavorable outcome after 6 months (mRS > 2) showed greater hemoglobin decline and increased cumulative fluid balance. A significant inverse relationship existed between fluid balance and hemoglobin decline. Thresholds for unfavorable outcome were 10.4 g/dL hemoglobin and 4894 mL cumulative fluid balance in the first 8 days. In multivariable analysis, fluid balance, but not fluid intake, remained significantly associated with unfavorable outcome, while the influence of hemoglobin lessened. Fluid balance but not hemoglobin related to secondary infarctions, with the effect being significant after inverse probability of treatment weighting. Transfusion was associated with unfavorable outcomes. CONCLUSIONS: Increased fluid balance influences hemoglobin decline through hemodilution. Fluid overload, rather than a slight decrease in hemoglobin levels, appears to be the primary factor contributing to poor outcomes in aSAH patients. The results suggest aiming for euvolemia and that a modest hemoglobin decline may be tolerated. It may be advisable to adopt a restrictive approach to transfusions, as they can potentially have a negative effect on outcome.


  • Open Access

    Analysis of Cerebral Spinal Fluid Drainage and Intracranial Pressure Peaks in Patients with Subarachnoid Hemorrhage

    by Anton Früh, Peter Truckenmüller, David Wasilewski, Peter Vajkoczy, Stefan Wolf, for the Earlydrain Study Group

    Background: After aneurysmal subarachnoid hemorrhage (aSAH), elevated intracranial pressure (ICP) due to disrupted cerebrospinal fluid (CSF) dynamics is a critical concern. An external ventricular drainage (EVD) is commonly employed for management; however, optimal strategies remain debated. The randomized controlled Earlydrain trial showed that an additional prophylactic lumbar drainage (LD) after aneurysm treatment improves neurological outcome. We performed a post hoc investigation on the impact of drainage volumes and critical ICP values on patient outcomes after aSAH. Methods: Using raw patient data from Earlydrain, we analyzed CSF drainage amounts and ICP measurements in the first 8 days after aSAH. Outcomes were the occurrence of secondary infarctions and the score on the modified Rankin scale after 6 months, dichotomized in values of 0–2 as favorable and 3–6 as unfavorable. Repeated measurements were considered with generalized estimation equations. Results: Earlydrain recruited 287 patients, of whom 221 received an EVD and 140 received an LD. Higher EVD volumes showed a trend to more secondary infarctions (p = 0.09), whereas higher LD volumes were associated with less secondary infarctions (p = 0.009). The mean total CSF drainage was 1052 ± 659 mL and did not differ concerning infarction and neurological outcome. Maximum ICP values were higher in patients with poor outcomes but not related to drainage volumes via EVD. After adjustment for aSAH severity and total CSF drainage, higher LD volume was linked to favorable outcome (per 100 mL: odds ratio 0.61 (95% confidence interval 0.39–0.95), p = 0.03), whereas higher EVD amounts were associated with unfavorable outcome (per 100 mL: odds ratio 1.63 (95% confidence interval 1.05–2.54), p = 0.03). Conclusions: Findings indicate that effects of CSF drainage via EVD and LD differ. Higher amounts and higher proportions of LD volumes were associated with better outcomes, suggesting a potential quantity-dependent protective effect. Optimizing LD volume and mitigating ICP spikes may be a strategy to improve patient outcomes after aSAH. Clinical trial registration: ClinicalTrials.gov identifier: NCT01258257.


  • Open Access

    Red Blood Cells in the Cerebrospinal Fluid Compartment After Subarachnoid Haemorrhage: Significance and Emerging Therapeutic Strategies

    by Soham Bandyopadhyay, Nina Schwendinger, Behnam Rezai Jahromi, Shivanand P. Lad, Spiros Blackburn, Stefan Wolf, Diederik Bulters, Ian Galea, Michael Hugelshofer

    Subarachnoid haemorrhage (SAH) is a subtype of stroke that predominantly impacts younger individuals. It is associated with high mortality rates and can cause long-term disabilities. This review examines the contribution of the initial blood load and the dynamics of clot clearance to the pathophysiology of SAH and the risk of adverse outcomes. These outcomes include hydrocephalus and delayed cerebral ischaemia (DCI), with a particular focus on the impact of blood located in the cisternal spaces, as opposed to ventricular blood, in the development of DCI. The literature described underscores the prognostic value of haematoma characteristics, such as volume, density, and anatomical location. The limitations of traditional radiographic grading systems are discussed, compared with the more accurate volumetric quantification techniques for predicting patient prognosis. Further, the significance of red blood cells (RBCs) and their breakdown products in secondary brain injury after SAH is explored. The review presents novel interventions designed to accelerate clot clearance or mitigate the effects of toxic byproducts released from erythrolysis in the cerebrospinal fluid following SAH. In conclusion, this review offers deeper insights into the complex dynamics of SAH and discusses the potential pathways available for advancing its management.